Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and ...
11d
Helix Launches Whole Exome+® Sequencing for Patients with Rare and Unexplained Genetic Conditions
Helix, the leading enterprise genomics platform, today announced the availability of Whole Exome+® Sequencing (WES+), a comprehensive diagnostic sequencing test now available to ordering providers ...
Expanded, pan-ethnic carrier screening is gaining traction, driven by cheaper sequencing, AI interpretation and digital counseling, with opportunities in clinics, fertility care and consumer ...
Demand is shifting to rapid, decentralized and at-home molecular testing, creating opportunities in consumables, multiplex panels, portable PCR, CRISPR diagnostics and Asia-Pacific expansion.Dublin, ...
The global pharmacogenomics market was valued at USD 5.7 billion in 2025 and is projected to reach USD 15.4 billion by 2035, growing at a CAGR of 10.6%. The global pharmacogenomics market is gaining m ...
According to MarketsandMarkets™, the Sepsis Diagnostics Market is projected to reach USD 1.22 billion by 2031 from USD 0.83 ...
The foundations of brain development are laid during a crucial period of pregnancy, and a common household plasticizer called DEHP may be quietly interfering with this process. Scientists have now ...
Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices, ...
The following biotech stocks reached a 52-week high on September 16, 2026, driven by positive results from clinical trials or an upcoming conference participation. BlossomHill Therapeutics is a ...
The NextSeq 550 System combines tried-and-true instrument technologies and tunable output with sequencing and array capabilities. Users can run transcriptome, targeted resequencing, genotyping, and ...
Whole Exome+ Sequencing integrates exome, mitochondrial, and digital karyotype analysis, aiming to reduce standalone CMA ...
An extensive, first-of-its-kind research study by ARUP Laboratories clarifies the clinical value of atypical findings from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results